Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Oncolytic Virotherapy Improves Immunotherapies Targeting Cancer Stemness in Glioblastoma Publisher Pubmed

Summary: Research suggests engineered viruses may boost brain cancer immunotherapy by attacking stem-like tumor cells and reshaping the tumor environment. #CancerResearch #Immunotherapy

Keshavarz M1 ; Dianatmoghadam H2, 3 ; Ghorbanhosseini SS4 ; Sarshari B5
Authors

Source: Biochimica et Biophysica Acta - General Subjects Published:2024


Abstract

Despite advances in cancer therapies, glioblastoma (GBM) remains the most resistant and recurrent tumor in the central nervous system. GBM tumor microenvironment (TME) is a highly dynamic landscape consistent with alteration in tumor infiltration cells, playing a critical role in tumor progression and invasion. In addition, glioma stem cells (GSCs) with self-renewal capability promote tumor recurrence and induce therapy resistance, which all have complicated eradication of GBM with existing therapies. Oncolytic virotherapy is a promising field of therapy that can kill tumor cells in a targeted manner. Manipulated oncolytic viruses (OVs) improve cancer immunotherapy by directly lysis tumor cells, infiltrating antitumor cells, inducing immunogenic cell death, and sensitizing immune-resistant TME to an immune-responsive hot state. Importantly, OVs can target stemness–driven GBM progression. In this review, we will discuss how OVs as a therapeutic option target GBM, especially the GSC subpopulation, and induce immunogenicity to remodel the TME, which subsequently enhances immunotherapies' efficiency. © 2024 Elsevier B.V.
Related Docs
View other Related Docs
1. Mesenchymal Stem Cell-Released Oncolytic Virus: An Innovative Strategy for Cancer Treatment, Cell Communication and Signaling (2023)
2. Oncolytic Newcastle Disease Virus Delivered by Mesenchymal Stem Cells-Engineered System Enhances the Therapeutic Effects Altering Tumor Microenvironment, Virology Journal (2020)
3. Engaging Stemness Improves Cancer Immunotherapy, Cancer Letters (2023)
Experts (# of related papers)
View all Related Experts
Hassan Dianat Moghadam (5)
Laleh Shariati (3)
Oncolytic Virotherapy Improves Immunotherapies Targeting Cancer Stemness in Glioblastoma
Other Related Docs
4. Oncolytic Virus Delivery Modulated Immune Responses Toward Cancer Therapy: Challenges and Perspectives, International Immunopharmacology (2022)
5. Immune Evader Cancer Stem Cells Direct the Perspective Approaches to Cancer Immunotherapy, Stem Cell Research and Therapy (2022)
6. Signaling Pathways Governing Glioma Cancer Stem Cells Behavior, Cellular Signalling (2023)
7. The Role of Hypoxia in the Tumor Microenvironment and Development of Cancer Stem Cell: A Novel Approach to Developing Treatment, Cancer Cell International (2021)
8. Advances in Bioengineered Car T/Nk Cell Therapy for Glioblastoma: Overcoming Immunosuppression and Nanotechnology-Based Strategies for Enhanced Car T/Nk Cell Therapy, Bioengineering and Translational Medicine (2025)
9. Lxr Inhibitor Sr9243-Loaded Immunoliposomes Modulate Lipid Metabolism and Stemness in Colorectal Cancer Cells, Medical Oncology (2023)
10. The Therapeutic Effect of Mscs and Their Extracellular Vesicles on Neuroblastoma, Progress in Biophysics and Molecular Biology (2024)
11. Advances in Bioengineered Car T/Nk Cell Therapy for Glioblastoma: Overcoming Immunosuppression and Nanotechnology-Based Strategies for Enhanced Car T/Nk Cell Therapy, Bioengineering and Translational Medicine (2024)
12. Targeting Immune Checkpoints: How to Use Natural Killer Cells for Fighting Against Solid Tumors, Cancer Communications (2023)
13. The Role of Natural Products As Inhibitors of Jak/Stat Signaling Pathways in Glioblastoma Treatment, Oxidative Medicine and Cellular Longevity (2022)
14. The Molecular Perspective on the Melanoma and Genome Engineering of T-Cells in Targeting Therapy, Environmental Research (2023)
15. Clinical Combinatorial Treatments Based on Cancer Vaccines: Combination With Checkpoint Inhibitors and Beyond, Current Drug Targets (2022)
16. Covid-19-Induced Stroke and the Potential of Using Mesenchymal Stem Cells-Derived Extracellular Vesicles in the Regulation of Neuroinflammation, Cellular and Molecular Neurobiology (2023)
17. Immunologic Tumor Microenvironment Modulators for Turning Cold Tumors Hot, Cancer Communications (2024)
18. Anti-Egfr Bioengineered Bacterial Outer Membrane Vesicles As Targeted Immunotherapy Candidate in Triple-Negative Breast Tumor Murine Model, Scientific Reports (2023)
19. Regenerative Medicine in Covid-19 Treatment: Real Opportunities and Range of Promises, Stem Cell Reviews and Reports (2021)
20. The Therapeutic Values of Il-7/Il-7R and the Recombinant Derivatives in Glioma: A Narrative Review, Journal of Interferon and Cytokine Research (2023)